Miguel Tejada suspended 105 games for amphetamines

70 Comments

We have likely seen the last of Miguel Tejada in MLB.

According to Jeff Passan of Yahoo! Sports, Tejada will be suspended 105 games following multiple positive tests for Adderall. He will begin serving the suspension immediately.

Tejada, 39, had already tested positive for amphetamines in the past, but he tested positive twice again recently. A second positive test carries a 25-game suspension while a third has an 80-game penalty, so that’s where the 105-game figure comes from. Players are allowed to use Adderall if they have a TUE (therapeutic use exemption), but Bob Nightengale of USA Today reports that Tejada’s expired on April 15.

This will be the third-longest non-lifetime suspension ever handed out by MLB, behind Alex Rodriguez (211 games) and Steve Howe (119 days). Tejada was recently moved to the 60-day disabled list with a calf strain, which essentially ruled him out for the rest of the season anyway. However, Passan hears that he is “strongly leaning toward retiring” rather than sit out the first 64 games next year.

Tejada, who won the AL MVP Award in 2002, made a comeback this season and was batting .288/.317/.378 with three home runs and 20 RBI over 53 games. He has previously admitted to buying human growth hormone while playing with the Athletics, but claims that he threw away the drugs before using them. Rafael Palmeiro infamously blamed his positive PED test on a B-12 shot he received from Tejada.

UPDATE: It’s official. Below is the announcement from MLB:

The Office of the Commissioner of Baseball announced today that Kansas City Royals infielder Miguel Tejada has received a 105-game suspension without pay after testing positive for an Amphetamine in violation of Major League Baseball’s Joint Drug Prevention and Treatment Program.  The suspension of Tejada is effective immediately.

Phillies, RHP Taijuan Walker reportedly agree to 4-year deal

Kyle Ross-USA TODAY Sports
0 Comments

SAN DIEGO – The active Philadelphia Phillies added Taijuan Walker to their rotation on Tuesday, agreeing to a $72 million, four-year contract with the right-hander.

A person familiar with the negotiations confirmed the move to The Associated Press on condition of anonymity because it was pending a physical.

It was the second major free-agent score for the Phillies at the winter meetings after they reeled in shortstop Trea Turner on Monday with a $300 million, 11-year deal. Walker and Turner join a Phillies team that made it to the World Series this year before losing to the Houston Astros.

The 30-year-old Walker went 12-5 with a 3.49 ERA in 29 starts this season for the New York Mets, one of Philadelphia’s biggest NL East rivals. He slots into a rotation fronted by Zack Wheeler and Aaron Nola.

The Phillies recently lost pitcher Zach Eflin in free agency to Tampa Bay.

Asked about the market for Walker earlier in the day, agent Scott Boras said it was robust.

“As you can see in the marketplace, there’s a whole number of pitchers that are throwing 60 and 70 innings that have been pursued, probably with the exception of (Jacob) deGrom, at the lower end of threshold around $13-15 million a year because the demand for quality pitching is so great,” Boras said.

“So, Tai … is one of the younger ones, one of the more durable ones and we expect him to be pursued greatly as his market unfolds.”

Walker was selected by Seattle with the No. 43 pick in the 2010 amateur draft. He made his big league debut with the Mariners in 2013.

Walker signed with New York as a free agent in February 2021. He turned down a $7.5 million player option last month in favor of a $3 million buyout, making his deal worth $17 million over two seasons.

The 6-foot-4 Walker made the All-Star team for the first time in 2021, putting together a fast start before fading to a 7-11 record with a 4.47 ERA in 30 games, 29 starts.